Neoadjuvant chemotherapy for early breast cancer in young patients: real-world outcomes

被引：0
|
作者：
Javed, S. R. [1 ]
Mathur, S. [1 ]
Desouza, K. [1 ]
Konstantis, A. [1 ]
Ottaviani, D. [1 ]
Raja, F. [1 ]
Roylance, R. [1 ]
Walsh, T. [1 ]
Papadimitraki, E. [1 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, London, England
来源：
CLINICAL ONCOLOGY | 2025年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real-World Assessment of Locoregional Management of the Axilla in Node-Positive Breast Cancer After Neoadjuvant Chemotherapy
    Fleshner, Katherine
    Xu, Yuan
    Isherwood, Susan
    Yang, Flora
    Pyo, Jade
    Blair, Akaya
    Hall, Juliette
    Hanniman, Emily
    Bouchard-Fortier, Antoine
    Quan, May Lynn
    ANNALS OF SURGICAL ONCOLOGY, 2025,
  • [42] Efficacy and safety of adding carboplatin in neoadjuvant chemotherapy for triple-negative breast cancer - real-world data
    Leung, K. H.
    Kwok, C. C. H.
    BREAST, 2025, 80
  • [43] Real-World Analysis of Patients Receiving Neoadjuvant Chemotherapy with and without Chemoradiation for Locally Advanced Rectal Cancer
    Buchheit, Joanna T.
    Janczewski, Lauren M.
    Wells, Amy
    Hardy, Ashley N.
    Abad, John
    Halverson, Amy
    Chawla, Akhil
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S130 - S130
  • [44] Neoadjuvant pyrotinib plus trastuzumab, and chemoterapy in patients with HER2-positive early breast cancer: a real-world study
    Zhou, Jun
    Wang, Rui
    CANCER RESEARCH, 2024, 84 (09)
  • [45] Local regional management of the axilla in node-positive breast cancer patients following neoadjuvant chemotherapy: An evaluation of real-world practice
    Fleshner, Katherine
    Quan, May-Lynn
    Bouchard-Fortier, Antoine
    Isherwood, Susan
    Xu, Yuan
    Hanniman, Emily
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 198 - 199
  • [46] Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data
    Deng, Heran
    Wang, Liying
    Wang, Na
    Zhang, Kejin
    Zhao, Yanxia
    Qiu, Pengfei
    Qi, Xiaowei
    Zhang, Danhua
    Xu, Fei
    Liu, Jieqiong
    BMC CANCER, 2023, 23 (01)
  • [47] Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data
    Heran Deng
    Liying Wang
    Na Wang
    Kejin Zhang
    Yanxia Zhao
    Pengfei Qiu
    Xiaowei Qi
    Danhua Zhang
    Fei Xu
    Jieqiong Liu
    BMC Cancer, 23
  • [48] Pathological complete response rates with the addition of carboplatin to standard neoadjuvant chemotherapy in a cohort of real-world patients with triple negative breast cancer
    Ramalho, S.
    dA Natal, R.
    Cardoso Filho, C.
    Xavier, M. B.
    da Silva, A. E. R.
    Silva, L. R.
    Vasconcelos, V.
    Reinert, T.
    Coelho, G. P.
    Silva, G. R. dP
    dos Santos, C. C.
    CANCER RESEARCH, 2019, 79 (04)
  • [49] Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
    Thanh-Tuan Nguyen
    Huillard, Olivier
    Dabi, Yohann
    Anract, Julien
    Sibony, Mathilde
    Zerbib, Marc
    Xylinas, Evanguelos
    FRONTIERS IN SURGERY, 2018, 5
  • [50] Real-World evidence for Pembrolizumab-based neoadjuvant chemotherapy in early-stage triple negative breast cancer: a single institution experience
    Al-Awadhi, Aydah
    AlShebli, Mouza
    Wahba, Lina
    Younis, Tallal
    CANCER RESEARCH, 2024, 84 (09)
12345